BE563791A - - Google Patents
Info
- Publication number
- BE563791A BE563791A BE563791DA BE563791A BE 563791 A BE563791 A BE 563791A BE 563791D A BE563791D A BE 563791DA BE 563791 A BE563791 A BE 563791A
- Authority
- BE
- Belgium
- Prior art keywords
- histamine
- composition
- globulin
- gamma
- acid
- Prior art date
Links
- NTYJJOPFIAHURM-UHFFFAOYSA-N histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 claims description 39
- 229960001340 histamine Drugs 0.000 claims description 20
- 239000000203 mixture Substances 0.000 claims description 17
- 108010074605 gamma-Globulins Proteins 0.000 claims description 8
- NBIIXXVUZAFLBC-UHFFFAOYSA-N phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims description 4
- 239000000470 constituent Substances 0.000 claims description 3
- 230000003603 histaminopectic Effects 0.000 claims description 3
- 241000282412 Homo Species 0.000 claims description 2
- 229940102223 Injectable Solution Drugs 0.000 claims description 2
- 241001465754 Metazoa Species 0.000 claims description 2
- 210000002966 Serum Anatomy 0.000 claims description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 claims description 2
- 150000007522 mineralic acids Chemical class 0.000 claims description 2
- 150000007524 organic acids Chemical class 0.000 claims description 2
- 239000011780 sodium chloride Substances 0.000 claims description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 2
- ZHLKXBJTJHRTTE-UHFFFAOYSA-N Chlorbenside Chemical compound C1=CC(Cl)=CC=C1CSC1=CC=C(Cl)C=C1 ZHLKXBJTJHRTTE-UHFFFAOYSA-N 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N HCl Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- 239000000739 antihistaminic agent Substances 0.000 description 4
- 230000001387 anti-histamine Effects 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 239000002253 acid Substances 0.000 description 2
- 239000000443 aerosol Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 230000001681 protective Effects 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 241000700199 Cavia porcellus Species 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 229940025708 Injectable Product Drugs 0.000 description 1
- 241000287531 Psittacidae Species 0.000 description 1
- 201000010000 agranulocytosis Diseases 0.000 description 1
- 201000005794 allergic hypersensitivity disease Diseases 0.000 description 1
- 125000002490 anilino group Chemical class [H]N(*)C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 1
- 230000000875 corresponding Effects 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000000644 isotonic solution Substances 0.000 description 1
- 230000002045 lasting Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 230000002588 toxic Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BE563791A true BE563791A (ja) |
Family
ID=184899
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BE563791D BE563791A (ja) |
Country Status (1)
| Country | Link |
|---|---|
| BE (1) | BE563791A (ja) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0094575A2 (en) * | 1982-05-17 | 1983-11-23 | MCMICHAEL, John | Compositions for treatment of disease states involving immunological factors |
-
0
- BE BE563791D patent/BE563791A/fr unknown
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0094575A2 (en) * | 1982-05-17 | 1983-11-23 | MCMICHAEL, John | Compositions for treatment of disease states involving immunological factors |
| EP0094575A3 (en) * | 1982-05-17 | 1984-10-10 | University Patents, Inc. | Methods and materials for treatment of disease states involving immunological factors |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU619930B2 (en) | Use of resiniferatoxin and analogues thereof to cause sensory afferent c-fiber and thermoregulatory desensitization | |
| Itzhak et al. | The neuronal nitric oxide synthase inhibitor, 7‐nitroindazole, protects against methamphetamine‐induced neurotoxicity in vivo | |
| DE69933738T2 (de) | Zusammensetzung, welche Aminosäuren und Trehalose enthält | |
| US20060147405A1 (en) | Method for treating urushiol induced contact dermatitis | |
| CA2625804A1 (fr) | Composition pharmaceutique a base d'un agent antimycotique morpholinique et d' un agent filmogene hydrosoluble pour application ungueale et peri-ungueale | |
| FR2758720A1 (fr) | Compositions cosmetiques de soins capillaires avec effet de suppression de formation de pellicules | |
| FR2778562A1 (fr) | Composition pharmaceutique, hygienique et/ou cosmetique contenant de l'eau de mer et de l'arginine | |
| EP1464330B1 (fr) | composition antiallergique comprenant des oligosaccharides et une saponine ou un acide aminé basique destinée à être administrée par voie topique ou par inhalation | |
| US6660304B2 (en) | Method of treating prickly heat | |
| BE563791A (ja) | ||
| Macrides et al. | Hepatoprotective effects of the shark bile salt 5β-scymnol on acetaminophen-induced liver damage in mice | |
| WO1999027902A1 (fr) | Composition comportant un n-undecylenoyl aminoacide; application en cosmetique | |
| EP0768887B1 (fr) | Compositions possedant des proprietes antivirales et procede d'obtention | |
| JPH04124140A (ja) | アンジオテンシン変換酵素阻害剤 | |
| TW200404567A (en) | Stabilised topical formulations containing ketoprofen | |
| CA2083825A1 (fr) | Nouvelle composition pharmaceutique a base de taurine pour l'administration par inhalation | |
| FR2787709A1 (fr) | Composition dermatologique nouvelle a base d'acide tannique et d'un inhibiteur de proliferation microbienne | |
| JP2000143513A (ja) | 外用組成物 | |
| EP1425296B1 (de) | Organische verbindungen mit biologischer wirkung als thrombinhemmer und ihre verwendung | |
| EP0618794B1 (fr) | Utilisation du methylsulfate de 4- (2-oxo-3-bornylidene)methyl]phenyltrimethylammonium dans une composition de deformation permanente des cheveux pour la protection contre les agressions atmospheriques, et en particulier contre la lumiere | |
| WO2005094806A1 (en) | Use of quaternary ammonium compounds as specific blockers of transport through aquaporin, compositions comprising the compounds and method of selecting the compounds | |
| Ay et al. | Effects of androctonus crassicauda scorpion venom on endothelium-dependent and-independent vascular responses of rabbit aorta | |
| US20040152682A1 (en) | Stabilized steroid composition and method for its preparation | |
| FR2814075A1 (fr) | Pommade nasale a base de vaseline et de tannis | |
| Ujváry et al. | Role of β-alanine in pupal cuticle coloration in the tobacco hornworm, Manduca sexta: Effects of β-alanine analogues on melanization and catecholamine levels |